Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Ten Subject, Double-Blind, Placebo-Controlled Trial of Single Day Dosing of Sublingual Flumazenil in Individuals With Primary Hypersomnia or Excessively Long Total Sleep Time and Excess Endogenous Potentiation of GABA-A Receptors

NCT01183312 is registered in ClinicalTrials.gov with Lynn Marie Trotti as lead sponsor.

NCT NCT01183312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01183312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Ten Subject, Double-Blind, Placebo-Controlled Trial of Single Day Dosing of Sublingual Flumazenil in Individuals With Primary Hypersomnia or Excessively Long Total Sleep Time and Excess Endogenous Potentiation of GABA-A Receptors
Lead sponsor
Lynn Marie Trotti
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2010
Completion date
January 31, 2012
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypersomnia, idiopathic hypersomnia, narcolepsy without cataplexy, primary hypersomnia